When someone seeks a second opinion in psychiatry, it is often interpreted as a sign that they do not trust their first psychiatrist.

That is not necessarily the case.

A psychiatric second opinion can serve a much more useful purpose:

to revisit the diagnosis, review previous treatment systematically, and determine whether the current formulation still makes sense.

This is particularly relevant in psychiatry because many disorders overlap considerably.

Depression can resemble bipolar depression.

Anxiety can resemble ADHD.

OCD may be mistaken for generalized anxiety.

Autism, ADHD, personality traits and trauma-related difficulties may coexist or resemble one another.

And a patient who appears to have “treatment-resistant depression” may actually have received several inadequate treatment trials—or may have another underlying diagnosis.

So what does international research actually tell us about the value of psychiatric second opinions?

The available evidence is smaller than one might expect, but several studies provide useful answers.

Psychiatric Second Opinions Are Most Often Requested for Difficult Cases

One of the most informative studies came from a tertiary psychiatric second-opinion clinic in Yorkshire in the United Kingdom.

Researchers examined 71 patients who had already been receiving specialist psychiatric care but were referred for an expert second opinion.

These were not routine psychiatric patients.

They were predominantly difficult cases.

The two major reasons for referral were:

• treatment failure — 62%
• diagnostic difficulty — 48%

After specialist reassessment, the psychiatrist reached a different diagnosis in 31% of patients.

Even more strikingly, an alternative medication strategy was recommended in 68%.

In other words, approximately one in three complex psychiatric referrals received a different diagnostic formulation, while treatment recommendations changed even more frequently.

That is an important finding.

It suggests that the greatest value of a second opinion may not necessarily be discovering that the original diagnosis was completely wrong.

More often, it may involve refining treatment strategy after looking at the entire illness again.

31% Diagnostic Change Does Not Mean Psychiatry Is “Wrong 31% of the Time”

This needs careful interpretation.

The Yorkshire patients were specifically referred because something was already difficult.

Many had failed treatment.

Others had unresolved diagnostic questions.

Therefore, the finding that 31% received a different diagnosis cannot simply be applied to every psychiatric consultation.

If 100 patients with straightforward panic disorder sought another psychiatrist tomorrow, we should not expect 31 of them to receive completely different diagnoses.

Second-opinion clinics concentrate diagnostic uncertainty.

That is precisely why the yield is higher.

The more appropriate conclusion is:

Among psychiatric patients already considered diagnostically difficult or treatment resistant, a specialist reassessment can change the working diagnosis in a substantial minority.

Treatment Recommendations May Change More Often Than Diagnosis

Perhaps the most practically important finding from the British study was not the 31% diagnostic change.

It was the 68% change in pharmacological strategy.

That makes intuitive sense.

Two psychiatrists may agree that someone has depression but disagree about:

• whether the previous antidepressant trials were adequate,
• whether augmentation should be attempted,
• whether psychotherapy has been sufficiently used,
• whether a mood stabilizer is justified,
• whether medication side effects outweigh benefits,
• or whether treatment should move toward an interventional option.

Thus, a second opinion can be valuable even when the original diagnosis is confirmed.

A different diagnosis is not the only meaningful outcome.

Psychosis Provides an Important Example

A more recent specialist second-opinion service at Massachusetts General Hospital and Harvard Medical School examined patients referred for diagnostic clarification involving schizophrenia-spectrum disorders.

Researchers analysed 177 referrals between 2017 and 2023.

Among 100 people who arrived without a schizophrenia diagnosis, 28% were ultimately diagnosed with schizophrenia after the specialist consultation.

The service also identified patients with treatment-resistant schizophrenia, which has major therapeutic implications because it raises consideration of clozapine.

Among patients ultimately classified as having treatment-resistant schizophrenia, 56% received that designation only after the specialist reassessment.

That did not merely change the wording in the case file.

It changed treatment recommendations.

A second opinion can therefore sometimes convert a vague description such as:

“schizophrenia not responding to treatment”

into a much more specific clinical question:

“Has this patient actually met criteria for treatment-resistant schizophrenia, and should clozapine now be considered?”

That is a clinically meaningful distinction.

Another Study Found Diagnostic Changes in Almost Half of Treatment-Refractory Psychosis Cases

An earlier study looked at 50 patients with treatment-refractory psychotic illness who underwent comprehensive reassessment.

The referring diagnosis changed in 23 of the 50 patients — approximately 46%.

One important pattern emerged.

After detailed reassessment, the specialist team diagnosed schizophrenia or schizoaffective disorder less frequently and mood disorders more frequently.

Treatment changed accordingly, with more patients subsequently receiving mood-stabilizing treatment.

Again, this should not be interpreted as a 46% error rate in ordinary psychiatric diagnosis.

These were particularly difficult, treatment-refractory patients.

But the study makes an important point:

When treatment repeatedly fails, returning to the diagnosis can sometimes be more useful than automatically adding another medication.

This Principle Extends Beyond Psychiatry

Large studies of medical second opinions across multiple specialties show a similar pattern.

In one programme involving nearly 6,800 second-opinion consultations, the second review resulted in:

• a different diagnosis in approximately 15%
• a different treatment recommendation in approximately 37%
• changes in both diagnosis and treatment in another 11%

Importantly, treatment recommendations changed more frequently than diagnoses.

This mirrors what the psychiatric literature suggests.

A second opinion is often valuable not because the first doctor misunderstood the illness completely, but because another specialist may identify a different route forward.

Systematic Reviews Show Wide Variation

When researchers have reviewed second-opinion studies across medicine, they have found enormous variation.

One systematic review from Mayo Clinic found that major changes in diagnosis, prognosis or treatment occurred in approximately 10% to 62% of cases depending on the population and speciality studied.

Another later review similarly found that disagreement between initial and second opinions could have potentially important implications in a substantial proportion of selected cases.

The range is so wide because the populations are completely different.

A second opinion requested by a healthy individual seeking reassurance is not comparable with a tertiary referral involving a five-year unresolved illness.

So the useful question is not:

“What percentage of second opinions disagree?”

It is:

“In which patients is disagreement most likely to matter?”

Psychiatric Diagnosis Is Particularly Dependent on Clinical Context

Psychiatry has an additional complexity.

There is often no single laboratory marker that determines the diagnosis.

The clinician integrates:

• symptoms,
• chronology,
• developmental history,
• family history,
• functional impairment,
• behavioural observations,
• medical history,
• substance use,
• treatment response,
• collateral information from relatives.

Different levels of information can therefore produce different formulations.

A large meta-analysis comparing routine psychiatric diagnoses with structured diagnostic interviews found only low-to-moderate overall agreement, with substantial differences between disorders.

This does not mean psychiatric diagnosis is arbitrary.

It means that how thoroughly a patient is assessed matters.

A ten-minute consultation and a ninety-minute longitudinal diagnostic review are not necessarily equivalent assessments.

Psychiatric Diagnoses Can Also Evolve Over Time

Another reason a second opinion may differ from the first is that the illness itself becomes clearer longitudinally.

Consider someone who initially presents with depression.

At that point, there may be no history of hypomania.

Two years later, the person develops a clear period of:

• decreased need for sleep,
• markedly increased activity,
• unusually elevated or irritable mood,
• excessive confidence,
• impulsive spending,
• racing thoughts.

The diagnosis may now shift toward bipolar disorder.

The original psychiatrist may not have “missed” information.

The information did not yet exist.

Psychiatric diagnosis often becomes more accurate as the longitudinal pattern emerges.

Bipolar Disorder Is a Good Example of Why Reassessment Matters

Bipolar disorder is particularly important because patients commonly seek help during depressive episodes rather than during hypomania.

A meta-analysis examining people diagnosed with depression in primary-care settings found that approximately 17% met criteria for previously unrecognised bipolar disorder when systematically reassessed.

This does not mean 17% of all depression is bipolar disorder.

But it demonstrates how easily bipolarity can remain hidden when the assessment focuses only on the current depressive episode.

Questions about:

• previous periods of reduced sleep,
• increased energy,
• unusual confidence,
• impulsivity,
• episodic irritability,
• increased activity

can substantially change the formulation.

This is exactly the kind of situation where a second psychiatric opinion may have real value.

“Treatment Resistance” Should Trigger Diagnostic Reassessment

One of the clearest lessons from the international literature is that repeated treatment failure should not automatically trigger treatment escalation.

It should also trigger diagnostic reassessment.

Suppose a patient has taken four antidepressants without meaningful improvement.

There are at least two possibilities.

The first is:

the patient genuinely has treatment-resistant depression.

The second is:

something important has been missed.

That could include:

• bipolar disorder,
• ADHD,
• OCD,
• PTSD,
• substance use,
• sleep disorder,
• personality-related difficulties,
• medical illness,
• inadequate medication duration,
• inadequate dose,
• poor adherence.

A second opinion can therefore be particularly valuable before moving toward interventions such as:

• complex augmentation,
• rTMS,
• ketamine,
• ECT,
• long-term polypharmacy.

The greater the proposed treatment complexity, the more important the diagnostic foundation becomes.

Second Opinions Can Be Particularly Useful in ADHD

Adult ADHD illustrates another modern diagnostic challenge.

A person may initially seek help for:

• anxiety,
• depression,
• occupational burnout,
• low self-esteem,
• relationship problems.

If the assessment concentrates only on current symptoms, treatment may focus exclusively on anxiety or depression.

But a detailed developmental history may reveal longstanding:

• procrastination,
• distractibility,
• disorganisation,
• inconsistent academic performance,
• forgetfulness,
• difficulty completing tasks.

In this situation, the correct formulation may be:

ADHD with secondary anxiety or depression

rather than:

primary anxiety disorder alone.

Conversely, anxiety can itself produce concentration problems.

A good second opinion therefore does not simply ask:

“Do you have attention problems?”

It asks:

“When did these problems begin, and what best explains them?”

Autism, ADHD and Personality Disorders Can Also Overlap

Adult neurodevelopmental assessment is another area where second opinions can be particularly useful.

Someone may have:

• social difficulties,
• emotional dysregulation,
• rigidity,
• sensory sensitivity,
• impulsivity,
• intense interests,
• unstable relationships.

Depending on which features dominate the consultation, different clinicians may initially consider:

• autism,
• ADHD,
• personality disorder,
• anxiety,
• trauma-related disorders,
• or combinations of these.

Developmental history becomes crucial.

A pattern present from childhood carries a different diagnostic meaning from symptoms emerging after major trauma or relationship disruption in adulthood.

Again, the value lies not in simply accumulating more labels.

It lies in building a better explanatory model of the person’s difficulties.

Polypharmacy Is Another Reason to Seek Review

Psychiatric medication regimens sometimes accumulate gradually.

A patient begins with one antidepressant.

Another medicine is added for sleep.

An antipsychotic is added for augmentation.

A benzodiazepine is introduced during a crisis.

A mood stabilizer is added later.

Several years later, the patient may be taking five medications—and nobody clearly remembers why each one remains necessary.

In such situations, a second opinion can provide a useful medication rationalisation review.

The questions are:

• What is each medicine treating?
• Which medications clearly helped?
• Which produced no measurable benefit?
• Which may now be causing problems?
• Can the regimen be simplified safely?

The purpose is not to stop medication indiscriminately.

It is to make sure every medication still has a defensible role.

The Best Second Opinion May Agree With the First

An important finding from the broader second-opinion literature is that many second opinions confirm the initial diagnosis or treatment plan.

That is not a failed second opinion.

Confirmation can:

• increase confidence,
• improve adherence,
• reduce doctor shopping,
• reassure families,
• strengthen justification for advanced treatment.

Imagine a patient uncertain about undergoing ECT after several unsuccessful treatments.

A second specialist independently concludes:

“Yes. The diagnosis is sound, the previous treatment trials were adequate, and ECT is a reasonable next step.”

That confirmation can be extremely valuable.

The purpose of a second opinion is not disagreement.

It is greater confidence in the decision.

A Second Opinion Is Not the Same as Doctor Shopping

There is an important distinction.

A second opinion asks:

“Can another clinician independently review my diagnosis and treatment?”

Doctor shopping asks:

“Can I keep consulting people until someone gives me the diagnosis or prescription I want?”

Repeatedly seeking new opinions without integrating previous assessments can actually increase confusion.

A useful second opinion should therefore be focused.

Examples include:

• Is this recurrent depression or bipolar disorder?
• Have my previous treatments genuinely failed?
• Do I really require this many medications?
• Could ADHD explain persistent anxiety and functional difficulty?
• Is this OCD rather than generalized anxiety?
• Should I proceed with rTMS, ketamine or ECT?
• Is this memory problem depression or possible cognitive decline?

The clearer the question, the more useful the consultation.

Which Patients Are Most Likely to Benefit?

Based on the available international evidence, the greatest value appears to be in people with:

• diagnostic uncertainty,
• several previous diagnoses,
• repeated treatment failures,
• treatment-resistant illness,
• significant medication side effects,
• psychiatric polypharmacy,
• possible bipolar disorder,
• psychosis with uncertain diagnosis,
• ADHD or autism overlap,
• complex cognitive symptoms,
• consideration of high-cost or invasive treatments.

For someone with straightforward, recently diagnosed anxiety responding well to treatment, another specialist review may add little.

For someone with ten years of illness, five diagnoses and twelve previous medications, the potential value is very different.

What Does the Global Evidence Ultimately Tell Us?

The research does not justify saying:

“Psychiatrists frequently get the diagnosis wrong.”

Nor does it justify saying:

“A second opinion will definitely discover something new.”

The evidence supports a more nuanced conclusion.

In ordinary medical second-opinion programmes, most initial diagnoses are broadly confirmed.

But treatment plans are changed more often than diagnoses.

And in selected complex psychiatric populations, specialist reassessment has produced substantial diagnostic and therapeutic changes.

The most useful figures from psychiatric studies include:

• 31% diagnostic change in a tertiary UK psychiatric second-opinion clinic
• 68% alternative medication strategy in the same service
• 46% diagnostic change among one group of treatment-refractory psychosis patients
• significant diagnostic clarification in a modern specialist schizophrenia second-opinion programme

These figures should not be applied to every psychiatric patient.

They illustrate something more important:

The harder the case, the greater the potential value of stepping back and rebuilding the formulation.

The Central Principle: Before Increasing Treatment Complexity, Increase Diagnostic Certainty

Psychiatry now has more treatment options than ever before.

Medication.

Psychotherapy.

rTMS.

Ketamine.

ECT.

Digital interventions.

Neuromodulation.

But every new treatment option makes diagnostic discipline more—not less—important.

A patient should not move automatically from:

one failed medicine,

to three medicines,

to five medicines,

to rTMS,

to ketamine,

simply because symptoms remain.

Sometimes escalation is exactly what is required.

But sometimes the most useful intervention is another careful assessment.

Before increasing treatment complexity, increase diagnostic certainty.

That may ultimately be the strongest argument for a psychiatric second opinion.

References

Key evidence discussed in this article includes published research on tertiary psychiatric second-opinion services, treatment-refractory psychosis, specialist schizophrenia reassessment, general medical second-opinion programmes, diagnostic agreement in psychiatry and previously unrecognised bipolar disorder among patients presenting with depression.

These studies consistently suggest that second opinions are most informative when the clinical problem is already complex rather than as routine duplication of straightforward psychiatric care.